Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

Pancreatic Cancer Treatment Market Growth & Trends

The global pancreatic cancer treatment market size is anticipated to reach USD 5.84 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.30% from 2025 to 2030. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Pancreatic Cancer Treatment Market Report Highlights

• The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types.
• Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells.
• North America dominated the segment with the largest revenue share in 2024 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure.
• Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment.

Please note The report will be delivered in 2-3 business days upon order notification.